| Primary |
| Pain |
46.2% |
| Anxiety |
7.7% |
| Arthralgia |
7.7% |
| Drug Abuse |
7.7% |
| Gout |
7.7% |
| Osteoarthritis |
7.7% |
| Procedural Pain |
7.7% |
| Sinusitis |
7.7% |
|
| Respiratory Arrest |
25.9% |
| Completed Suicide |
22.2% |
| Syncope |
7.4% |
| Atrial Fibrillation |
3.7% |
| Cardiac Arrest |
3.7% |
| Dizziness |
3.7% |
| Drug Abuser |
3.7% |
| Intentional Drug Misuse |
3.7% |
| Intestinal Obstruction |
3.7% |
| Liver Disorder |
3.7% |
| Loss Of Consciousness |
3.7% |
| Nausea |
3.7% |
| Palpitations |
3.7% |
| Product Quality Issue |
3.7% |
| Visual Impairment |
3.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
45.3% |
| Product Used For Unknown Indication |
24.8% |
| Ill-defined Disorder |
3.5% |
| Type 2 Diabetes Mellitus |
3.2% |
| Hypertension |
3.0% |
| Back Pain |
2.8% |
| Rheumatoid Arthritis |
2.6% |
| Suicide Attempt |
2.5% |
| Depression |
2.1% |
| Drug Abuser |
1.3% |
| Intentional Overdose |
1.2% |
| Medication Error |
1.2% |
| Pain |
1.2% |
| Sciatica |
1.2% |
| Postoperative Care |
0.9% |
| Anaesthesia |
0.8% |
| General Anaesthesia |
0.7% |
| Unevaluable Event |
0.7% |
| Completed Suicide |
0.6% |
| Diabetes Mellitus |
0.6% |
|
| Completed Suicide |
18.3% |
| Respiratory Arrest |
15.6% |
| Death |
10.0% |
| Cardio-respiratory Arrest |
8.3% |
| Drug Toxicity |
7.8% |
| Poisoning |
6.1% |
| Intentional Drug Misuse |
4.4% |
| Toxicity To Various Agents |
4.4% |
| Urine Output Decreased |
3.3% |
| Inappropriate Antidiuretic Hormone Secretion |
2.8% |
| Aortic Valve Incompetence |
2.2% |
| Drug Abuse |
2.2% |
| Somnolence |
2.2% |
| Tricuspid Valve Disease |
2.2% |
| Cytolytic Hepatitis |
1.7% |
| Gamma-glutamyltransferase Increased |
1.7% |
| Hepatitis Acute |
1.7% |
| Intentional Overdose |
1.7% |
| Pulmonary Oedema |
1.7% |
| Tremor |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.7% |
| Drug Use For Unknown Indication |
31.7% |
| Rheumatoid Arthritis |
6.6% |
| Pain |
6.0% |
| Hypertension |
2.3% |
| Premenstrual Syndrome |
1.5% |
| Crohn's Disease |
1.3% |
| Osteoporosis |
1.1% |
| Depression |
1.1% |
| Anxiety |
1.0% |
| Migraine |
1.0% |
| Back Pain |
0.9% |
| Polycystic Ovaries |
0.9% |
| Insomnia |
0.9% |
| Vitamin Supplementation |
0.9% |
| Constipation |
0.8% |
| Contraception |
0.7% |
| Prostate Cancer |
0.6% |
| Psoriatic Arthropathy |
0.6% |
| Nausea |
0.6% |
|
| Weight Decreased |
15.2% |
| Vomiting |
12.3% |
| Cholecystitis Chronic |
8.2% |
| Suicidal Ideation |
7.0% |
| Myocardial Infarction |
4.7% |
| Malaise |
4.1% |
| Pneumonia |
4.1% |
| Rheumatoid Arthritis |
4.1% |
| Subileus |
4.1% |
| Thrombosis |
4.1% |
| Death |
3.5% |
| Pulmonary Embolism |
3.5% |
| Renal Failure Acute |
3.5% |
| Urinary Tract Infection |
3.5% |
| Visual Impairment |
3.5% |
| Drug Eruption |
2.9% |
| General Physical Health Deterioration |
2.9% |
| Hypotension |
2.9% |
| Injection Site Pain |
2.9% |
| Lung Disorder |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Product Used For Unknown Indication |
12.5% |
| Asthma |
4.2% |
| Atrial Fibrillation |
4.2% |
| Cardiac Failure Congestive |
4.2% |
| Depression |
4.2% |
| Epilepsy |
4.2% |
| Hyperthyroidism |
4.2% |
| Mania |
4.2% |
| Oral Candidiasis |
4.2% |
| Toothache |
4.2% |
|
| Drug Interaction |
20.0% |
| Fall |
20.0% |
| Hepatitis |
20.0% |
| International Normalised Ratio Increased |
20.0% |
| Nystagmus |
20.0% |
|
